From 744b2e8f1e205c4497e35d628b2adefd6f3f0999 Mon Sep 17 00:00:00 2001 From: Nicky Case Date: Wed, 29 Apr 2020 22:05:19 -0400 Subject: [PATCH] yerf --- COPYING.txt | 116 ++++++++++++++ css/index.css | 70 +++++++++ favicon.png | Bin 0 -> 579 bytes index.html | 342 ++++++++++++++++++++++++++++++++++++++++-- js/blerp.js | 25 +++ sharing/cc0.png | Bin 0 -> 6364 bytes sharing/thumbnail.png | Bin 0 -> 46653 bytes sim/index.html | 2 +- sim/js/Model.js | 14 +- words/words.md | 291 +++++++++++++++++++---------------- 10 files changed, 710 insertions(+), 150 deletions(-) create mode 100644 COPYING.txt create mode 100644 favicon.png create mode 100644 js/blerp.js create mode 100644 sharing/cc0.png create mode 100644 sharing/thumbnail.png diff --git a/COPYING.txt b/COPYING.txt new file mode 100644 index 0000000..670154e --- /dev/null +++ b/COPYING.txt @@ -0,0 +1,116 @@ +CC0 1.0 Universal + +Statement of Purpose + +The laws of most jurisdictions throughout the world automatically confer +exclusive Copyright and Related Rights (defined below) upon the creator and +subsequent owner(s) (each and all, an "owner") of an original work of +authorship and/or a database (each, a "Work"). + +Certain owners wish to permanently relinquish those rights to a Work for the +purpose of contributing to a commons of creative, cultural and scientific +works ("Commons") that the public can reliably and without fear of later +claims of infringement build upon, modify, incorporate in other works, reuse +and redistribute as freely as possible in any form whatsoever and for any +purposes, including without limitation commercial purposes. These owners may +contribute to the Commons to promote the ideal of a free culture and the +further production of creative, cultural and scientific works, or to gain +reputation or greater distribution for their Work in part through the use and +efforts of others. + +For these and/or other purposes and motivations, and without any expectation +of additional consideration or compensation, the person associating CC0 with a +Work (the "Affirmer"), to the extent that he or she is an owner of Copyright +and Related Rights in the Work, voluntarily elects to apply CC0 to the Work +and publicly distribute the Work under its terms, with knowledge of his or her +Copyright and Related Rights in the Work and the meaning and intended legal +effect of CC0 on those rights. + +1. Copyright and Related Rights. A Work made available under CC0 may be +protected by copyright and related or neighboring rights ("Copyright and +Related Rights"). Copyright and Related Rights include, but are not limited +to, the following: + + i. the right to reproduce, adapt, distribute, perform, display, communicate, + and translate a Work; + + ii. moral rights retained by the original author(s) and/or performer(s); + + iii. publicity and privacy rights pertaining to a person's image or likeness + depicted in a Work; + + iv. rights protecting against unfair competition in regards to a Work, + subject to the limitations in paragraph 4(a), below; + + v. rights protecting the extraction, dissemination, use and reuse of data in + a Work; + + vi. database rights (such as those arising under Directive 96/9/EC of the + European Parliament and of the Council of 11 March 1996 on the legal + protection of databases, and under any national implementation thereof, + including any amended or successor version of such directive); and + + vii. other similar, equivalent or corresponding rights throughout the world + based on applicable law or treaty, and any national implementations thereof. + +2. Waiver. To the greatest extent permitted by, but not in contravention of, +applicable law, Affirmer hereby overtly, fully, permanently, irrevocably and +unconditionally waives, abandons, and surrenders all of Affirmer's Copyright +and Related Rights and associated claims and causes of action, whether now +known or unknown (including existing as well as future claims and causes of +action), in the Work (i) in all territories worldwide, (ii) for the maximum +duration provided by applicable law or treaty (including future time +extensions), (iii) in any current or future medium and for any number of +copies, and (iv) for any purpose whatsoever, including without limitation +commercial, advertising or promotional purposes (the "Waiver"). Affirmer makes +the Waiver for the benefit of each member of the public at large and to the +detriment of Affirmer's heirs and successors, fully intending that such Waiver +shall not be subject to revocation, rescission, cancellation, termination, or +any other legal or equitable action to disrupt the quiet enjoyment of the Work +by the public as contemplated by Affirmer's express Statement of Purpose. + +3. Public License Fallback. Should any part of the Waiver for any reason be +judged legally invalid or ineffective under applicable law, then the Waiver +shall be preserved to the maximum extent permitted taking into account +Affirmer's express Statement of Purpose. In addition, to the extent the Waiver +is so judged Affirmer hereby grants to each affected person a royalty-free, +non transferable, non sublicensable, non exclusive, irrevocable and +unconditional license to exercise Affirmer's Copyright and Related Rights in +the Work (i) in all territories worldwide, (ii) for the maximum duration +provided by applicable law or treaty (including future time extensions), (iii) +in any current or future medium and for any number of copies, and (iv) for any +purpose whatsoever, including without limitation commercial, advertising or +promotional purposes (the "License"). The License shall be deemed effective as +of the date CC0 was applied by Affirmer to the Work. Should any part of the +License for any reason be judged legally invalid or ineffective under +applicable law, such partial invalidity or ineffectiveness shall not +invalidate the remainder of the License, and in such case Affirmer hereby +affirms that he or she will not (i) exercise any of his or her remaining +Copyright and Related Rights in the Work or (ii) assert any associated claims +and causes of action with respect to the Work, in either case contrary to +Affirmer's express Statement of Purpose. + +4. Limitations and Disclaimers. + + a. No trademark or patent rights held by Affirmer are waived, abandoned, + surrendered, licensed or otherwise affected by this document. + + b. Affirmer offers the Work as-is and makes no representations or warranties + of any kind concerning the Work, express, implied, statutory or otherwise, + including without limitation warranties of title, merchantability, fitness + for a particular purpose, non infringement, or the absence of latent or + other defects, accuracy, or the present or absence of errors, whether or not + discoverable, all to the greatest extent permissible under applicable law. + + c. Affirmer disclaims responsibility for clearing rights of other persons + that may apply to the Work or any use thereof, including without limitation + any person's Copyright and Related Rights in the Work. Further, Affirmer + disclaims responsibility for obtaining any necessary consents, permissions + or other rights required for any use of the Work. + + d. Affirmer understands and acknowledges that Creative Commons is not a + party to this document and has no duty or obligation with respect to this + CC0 or use of the Work. + +For more information, please see + diff --git a/css/index.css b/css/index.css index d721760..c9e29e0 100644 --- a/css/index.css +++ b/css/index.css @@ -9,6 +9,13 @@ b, strong{ font-weight: bold; } +a{ + color: #ff4040; +} +a:hover{ + color: #ff8080; +} + article > p, article > ul, article > ol, article > h1, article > h2, article > h3{ width: 640px; margin:1em auto; @@ -87,4 +94,67 @@ sub{ left: calc(50% + 358px); text-align: right; } +#translations a, #sharing a{ + color: #aaa; +} +#translations a:hover, #sharing a:hover{ + color: #ccc; +} +#share_title, #share_desc{ + display:none; +} +#footer{ + background: #000; + color: #fff; + overflow: hidden; + margin-top: 2em; +} +#footer > div{ + width:960px; + margin:3em auto; +} + +#supporters{ + color: #999; + font-size: 19px; + line-height: 1.3em; + columns:5; + text-align: center; +} + +#footnotes_container{ + background: #444; + color: #bbb; + padding-top: 2em; + padding-bottom: 1.5em; +} +#footnotes_container h2{ + margin: 0 auto; + text-align: center; +} +.footnotes{ + display: none; + width: 800px; + font-size: 16px; + line-height: 1.3em; + margin: 0 auto; +} +.footnotes hr/*, .footnotes a*/{ + display: none; +} +#show_feetnotes_button{ + cursor: pointer; +} +#show_feetnotes_button:hover{ + color: #fff; +} +#shown_feetnotes{ + display: none; +} + +#wash{ + font-size: 12px; + text-align: right; + padding: 0.5em 1.5em; +} \ No newline at end of file diff --git a/favicon.png b/favicon.png new file mode 100644 index 0000000000000000000000000000000000000000..f3516db886a545279d289f921e9bb656d0b0f623 GIT binary patch literal 579 zcmV-J0=)f+P)5QRTve5X1vJBUhvG`dF}gs#9&1yL%9I`HZp!l8KNaA}D`4W93R9L(*AVb2*m^wL3vz&m zYmn;#M5e8lsmx}dBY8659{2_90J(@A@CXFw-zW*&0=%f-%J>Pej`S5Srv>(xo#7p5 zZoh|B#sa)KlBFXuttef4(VnOY2$97E06YONgm=mB&azj4EEbtUkjs32+ap55yVlX& zf#b1z{vLJRSwSLv&Z=KP9AgAzoUd`GP`d&|Y$TbD9Fay|0y(fDP#;5gz&}z$$fu6{ zE;J}4AWk4sBnsF#^0h_|`a=|hO&If&Q@s?NuBVEQ8Hu&ho8FkE*=}DVBX*n~Gu3T9 z8b^>^VDUo5k(Vi{nl%u61Dfc&j+R6RZ3^gLnMdB^j<4v(6%i0}K@B3>3Nzrliz^C% zrBX8wz{&zieIfiAmV(^z(VGC|y(-QvrBkCdq!Uh(GYnnn`#< R$VvbJ002ovPDHLkV1nR}{iFZ@ literal 0 HcmV?d00001 diff --git a/index.html b/index.html index 9b683fb..3235f7b 100644 --- a/index.html +++ b/index.html @@ -3,33 +3,61 @@ + + What Happens Next? COVID-19 Futures, Explained With Playable Simulations + + - What Happens Next? COVID-19 Futures, Explained With Playable Simulations + + + + + + + + + + + + + + + + - -
No translations yet! -
- Help make one? + + Help make one? +
Help this guide get R > 1:
- Help make one? + + What Happens Next? COVID-19 Futures, Explained With Playable Simulations + + + 🔬 Here's a real deep dive! 28 min read/play: + +
-
+ + + + + +
+
+
+

What Happens Next?

+

COVID-19 Futures, Explained With Playable Simulations

+

by Marcel Salathé (epidemiologist) and Nicky Case (art/code)

+

🕐 28 min play/read

+
+
+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+

foo bar foo bar foo bar

+
+
+
    + +
  1. +

    (NOTE: This guide was published on April 30th, 2020. Many details will become outdated, but Epidemiology 101 will remain true, and we're confident this guide will cover 95% of possible futures.) ↩

    +
    2. + +
  2. +

    https://wwwnc.cdc.gov/eid/article/26/6/20-0357_article ↩

    +
    3. + +
  3. +

    source ↩

    +
    4. + +
  4. +

    https://link.springer.com/article/10.1007/s11427-020-1661-4 ↩

    +
    5. + +
  5. +

    source, and sidenote on 'infectious' ↩

    +
    6. + +
  6. +

    source ↩

    +
    7. + +
  7. +

    source ↩

    +
    8. + +
  8. +

    https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-14-480 ↩

    +
    9. + +
  9. +

    https://pubmed.ncbi.nlm.nih.gov/31995857/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001239/ ↩

    +
    10. + +
  10. +

    https://wwwnc.cdc.gov/eid/article/26/7/20-0282_article ↩

    +
    11. + +
  11. +

    sas ↩

    +
    12. + +
  12. +

    exact formula... ↩

    +
    13. + +
  13. +

    https://www.statista.com/statistics/1105420/covid-icu-admission-rates-us-by-age-group/ Lower end, 5%. ↩

    +
    14. + +
  14. +

    https://sccm.org/Blog/March-2020/United-States-Resource-Availability-for-COVID-19 ↩

    +
    15. + +
  15. +

    https://www.theatlantic.com/health/archive/2020/03/coronavirus-pandemic-herd-immunity-uk-boris-johnson/608065/ ↩

    +
    16. + +
  16. +

    https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-3156.2006.01568.x ↩

    +
    17. + +
  17. +

    https://cmmid.github.io/topics/covid19/comix-impact-of-physical-distance-measures-on-transmission-in-the-UK.html ↩

    +
    18. + +
  18. +

    log scale ↩

    +
    19. + +
  19. +

    https://science.sciencemag.org/content/early/2020/04/14/science.abb5793? ↩

    +
    20. + +
  20. +

    https://journals.sagepub.com/doi/abs/10.1177/1745691614568352 ↩

    +
    21. + +
  21. +

    sources plz, esp for incubation period 5 days ↩

    +
    22. + +
  22. +

    https://www.nature.com/articles/s41591-020-0869-5 ↩

    +
    23. + +
  23. +

    asds ↩

    +
    24. + +
  24. +

    https://science.sciencemag.org/content/early/2020/04/09/science.abb6936 ↩

    +
    25. + +
  25. +

    incoming ↩

    +
    26. + +
  26. +

    outgoing_aerosols ↩

    +
    27. + +
  27. +

    outgoing_droplets ↩

    +
    28. + +
  28. +

    homemade ↩

    +
    29. + +
  29. +

    ss ↩

    +
    30. + +
  30. +

    That BMJ article ↩

    +
    31. + +
  31. +

    s ↩

    +
    32. + +
  32. +

    ss ↩

    +
    33. + +
  33. +

    s ↩

    +
    34. + +
  34. +

    https://papers.ssrn.com/sol3/Papers.cfm?abstract_id=3551767 The average R-value of these 100 cities is 1.83 , One-degree Celsius increase in temperature and one percent increase in relative humidity lower R by 0.0225  ↩

    +
    35. + +
  35. +

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851497/ ↩

    +
    36. + +
  36. +

    https://pubmed.ncbi.nlm.nih.gov/2170159/ ↩

    +
    37. + +
  37. +

    https://www.nature.com/articles/d41586-020-01063-8 ↩

    +
    38. + +
  38. +

    https://www.nature.com/articles/d41586-020-00751-9 ↩

    +
    39. + +
  39. +

    https://www.statnews.com/2020/04/01/navigating-covid-19-pandemic/ ↩

    +
    40. + +
+
+
+ + + + +
+

(Click to show Feetnotes)

+

Feetnotes: +

+ +
+ wash your hands! 👏 +
+ + +